Discovery of A class GPCR ligands for probing signal transduction pathways
G protein–coupled receptors (GPCRs) are seven integral transmembrane proteins that are the primary targets of almost 30% of approved drugs and continue to represent a major focus of pharmaceutical research. All of GPCR targeted medicines were discovered by classical medicinal chemistry approaches. A...
Main Authors: | Simone eBrogi, Canan G. Nebigil-Desaubry, Andrea eTafi, Laurent G. Désaubry |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00255/full |
Similar Items
-
Editorial: New approaches for the discovery of GPCR ligands
by: Paula Morales, et al.
Published: (2023-08-01) -
Ligand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
by: Sara Patruno, et al.
Published: (2018-08-01) -
Structural features of arrestin-mediated GPCR signaling
by: Wenqin Xie, et al.
Published: (2024-12-01) -
Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
by: Kathryn E Livingston, et al.
Published: (2018-06-01) -
A computational model for GPCR-ligand interaction prediction
by: Karimi Shiva, et al.
Published: (2020-12-01)